NCT00370162

CompletedPhase 3

Acceptability Dermacyd Delicata - New Fragrance - Lactoserum...

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACTO_L_01839

Study Type

interventional

Reported enrollment (type unavailable)

30

Locations

1 country

Sites

1

Timeline

Study Start

June 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

Not reported

Date not reported

Brief Summary

The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 30 participants
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 2006
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
August 29, 2006
Actual (reported)
First Posted
August 30, 2006
Actual (reported)

Last Updated: May 16, 2008
Status Verified: May 2008
Last Update Submitted: May 15, 2008

Conditions

Hygiene

Outcome Measures

Primary Outcomes (1)

Adverse Events and its association with the drug in study

Interventions

lactoserumDrug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Integral skin in the tested region

You may not qualify if:

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-Aventis

São Paulo, Brazil

MeSH Terms

Interventions

lactoserum

Study Officials

Jaderson Lima
Sanofi
STUDY DIRECTOR

Study Design

Study Type: interventional
Phase: phase 3
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

August 29, 2006

First Posted

August 30, 2006

Study Start

June 2006

Date type not reported

This date has not been verified as actual or estimated.

Last Updated

May 16, 2008

Record last verified: 2008-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.